Internal Medicine, Pulmonary Disease · Los Angeles, CA
NPI
1063617116
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
200 Med Plz, Suite 365
Los Angeles, CA, 90095
Phone (310) 825-8061
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
499 services
Medicare patients, 2024
115
Average age 68
Drug cost, 2024
$2.0M
1,718 prescriptions
Company payments, 2025
$21K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen S Weigt was code 99233 (hospital e&m - subsequent), 114 times for 35 patients. In total Stephen S Weigt billed 499 services in 20 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 114 | 35 | $97.35 | $11K |
| 99214 Office E&M - Established | Facility | 101 | 51 | $70.18 | $7,088 |
| 99215 Office E&M - Established | Facility | 82 | 43 | $111.05 | $9,106 |
| 99232 Hospital E&M - Subsequent | Facility | 62 | 29 | $65.03 | $4,032 |
| 99213 Office E&M - Established | Facility | 25 | 19 | $49.21 | $1,230 |
| 31624 Bronchoscopy | Facility | 18 | 14 | $43.05 | $775 |
| 94618 Pulmonary Function Testing | Facility | 17 | 12 | $15.97 | $272 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $142.95 | $2,001 |
| 99213 Office E&M - Established | Office | 12 | 12 | $74.81 | $898 |
By year: 2022 $65K for 661 services; 2023 $49K for 526 services; 2024 $42K for 499 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen S Weigt prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 147 prescriptions and refills. In total Stephen S Weigt wrote 1,718 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 147 | 353 | 43 | $1,254 |
| Prednisone Generic | 142 | 290 | 39 | $1,061 |
| Azithromycin Generic | 107 | 265 | 32 | $2,068 |
| Pantoprazole Sodium Generic | 94 | 279 | 30 | $1,799 |
| Valganciclovir Hcl Generic | 86 | 216 | 24 | $18K |
| Ofev Nintedanib Esylate | 65 | 67 | Under 11 | $868K |
| Tacrolimus Generic | 57 | 102 | 12 | $9,962 |
| Alendronate Sodium Generic | 55 | 152 | 19 | $644 |
| Metoprolol Tartrate Generic | 52 | 137 | 21 | $486 |
| Pravastatin Sodium Generic | 48 | 136 | 18 | $719 |
| Cresemba Isavuconazonium Sulfate | 46 | 46 | Under 11 | $259K |
| Acyclovir Generic | 45 | 123 | 14 | $1,201 |
| Posaconazole Generic | 43 | 43 | Under 11 | $40K |
| Amlodipine Besylate Generic | 33 | 71 | Under 11 | $155 |
| Valacyclovir Valacyclovir Hcl | 30 | 44 | Under 11 | $1,398 |
Brand drugs: 286 claims; generic drugs: 1,432 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen S Weigt $21K ($21K in general payments such as food, travel and fees and $90.35 for research) from 5 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $21K |
| Sanofi-Aventis U.S. LLC SNY | 1 | $90.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.